Abstract
Background
Falls and related injuries are common among older people, and several drug classes are considered to increase fall risk.
Aims
This study aimed to investigate the association between the use of certain drug classes and falls in older nursing home residents in Sweden, and relate these to different age groups.
Methods
Information on falls that occurred in the previous year and regular use of possible fall risk drugs including non-benzodiazepine hypnotics (zopiclone and zolpidem) was collected from 331 nursing home residents during 2008–2011. Over the following 6 months, the occurrence of serious falls, requiring a physician visit or hospital care, was registered. Association between serious falls and drug use was compared between an older (≥ 85 years) and a younger group.
Results
An increased fall risk (Downton Fall Risk Index ≥ 3) was found in 93% of the study subjects (aged 65–101 years). Baseline data indicated an association between falls that occurred in the previous year and regular use of non-benzodiazepine hypnotics (p = 0.005), but not with the other studied drug classes. During the following 6 months, an association between use of non-benzodiazepine hypnotics and serious falls in the older group (p = 0.017, odds ratio 4.311) was found. No association was found between the other studied drug classes and serious falls.
Discussion
These results indicate an association between falls and the use of non-benzodiazepine hypnotics, compounds that previously have been considered generally well-tolerated in older people.
Conclusions
Caution is advocated when using non-benzodiazepine hypnotics regularly in older people living in nursing homes.
Similar content being viewed by others
References
World Health Organization (2007) WHO global report on falls prevention in older age. http://www.who.int/ageing/publications/Falls_prevention7March.pdf?ua=1. Accessed 23 Aug 2018
Panel on Prevention of Falls in Older Persons AGSaBGS (2011) Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 59:148–157. https://doi.org/10.1111/j.1532-5415.2010.03234.x
Maher RL, Hanlon J, Hajjar ER (2014) Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 13:57–65. https://doi.org/10.1517/14740338.2013.827660
Beers MH, Ouslander JG, Rollingher I et al (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151:1825–1832
Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157:1531–1536
Fick DM, Cooper JW, Wade WE et al (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163:2716–2724. https://doi.org/10.1001/archinte.163.22.2716
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60:616–631. https://doi.org/10.1111/j.1532-5415.2012.03923.x
The American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63:2227–2246. https://doi.org/10.1111/jgs.13702
Gallagher P, Ryan C, Byrne S et al (2008) STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46:72–83
O’Mahony D, O’Sullivan D, Byrne S et al (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44:213–218. https://doi.org/10.1093/ageing/afu145
Hartikainen S, Lonnroos E, Louhivuori K (2007) Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 62:1172–1181
National Board of Health and Welfare (Socialstyrelsen) (2010) Indicators of good pharmaceutical treatment in elderly (in Swedish; Indikatorer för god läkemedelsterapi hos äldre). http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18085/2010-6-29.pdf. Accessed 23 Aug 2018
Woolcott JC, Richardson KJ, Wiens MO et al (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169:1952–1960. https://doi.org/10.1001/archinternmed.2009.357
Park H, Satoh H, Miki A et al (2015) Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol 71:1429–1440. https://doi.org/10.1007/s00228-015-1955-3
Cox CA, van Jaarsveld HJ, Houterman S et al (2016) Psychotropic drug prescription and the risk of falls in nursing home residents. J Am Med Dir Assoc 17:1089–1093. https://doi.org/10.1016/j.jamda.2016.07.004
Rojas-Fernandez C, Dadfar F, Wong A et al (2015) Use of fall risk increasing drugs in residents of retirement villages: a pilot study of long term care and retirement home residents in Ontario, Canada. BMC Res Notes 8:568. https://doi.org/10.1186/s13104-015-1557-2
Olazaran J, Valle D, Serra JA et al (2013) Psychotropic medications and falls in nursing homes: a cross-sectional study. J Am Med Dir Assoc 14:213–217. https://doi.org/10.1016/j.jamda.2012.10.020
Berry SD, Lee Y, Cai S et al (2013) Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med 173:754–761. https://doi.org/10.1001/jamainternmed.2013.3795
Ernsth Bravell M, Westerlind B, Midlov P et al (2011) How to assess frailty and the need for care? Report from the Study of Health and Drugs in the Elderly (SHADES) in community dwellings in Sweden. Arch Gerontol Geriatr 53:40–45. https://doi.org/10.1016/j.archger.2010.06.011
World Health Organization ATC—Structure and Principles (2018) WHO Collaborating Centre for Drug Statistics Methodology. https://www.whocc.no/atc/structure_and_principles/. Accessed 23 Aug 2018
World Health Organization (1992) International statistical classification of diseases and related health problems (ICD-10), 10th edn. WHO, Geneva
Downton JH (1993) Falls in the elderly. Edward Arnold, London, pp 128–130
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Deandrea S, Bravi F, Turati F et al (2013) Risk factors for falls in older people in nursing homes and hospitals. A systematic review and meta-analysis. Arch Gerontol Geriatr 56:407–415. https://doi.org/10.1016/j.archger.2012.12.006
Navarro A, Ancizu I (2009) Analyzing the occurrence of falls and its risk factors: some considerations. Prev Med 48:298–302. https://doi.org/10.1016/j.ypmed.2008.12.019
Pandya N, Bookhart B, Mody SH et al (2008) Study of anemia in long-term care (SALT): prevalence of anemia and its relationship with the risk of falls in nursing home residents. Curr Med Res Opin 24:2139–2149. https://doi.org/10.1185/03007990802215844
Nazir A, Mueller C, Perkins A et al (2012) Falls and nursing home residents with cognitive impairment: new insights into quality measures and interventions. J Am Med Dir Assoc 13:819.e811–819.e816. https://doi.org/10.1016/j.jamda.2012.07.018
Becker C, Rapp K (2010) Fall prevention in nursing homes. Clin Geriatr Med 26:693–704. https://doi.org/10.1016/j.cger.2010.07.004
Johnell K, Fastbom J (2012) Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. Drugs Aging 29:751–758. https://doi.org/10.1007/s40266-012-0002-7
Gustafsson M, Karlsson S, Gustafson Y et al (2013) Psychotropic drug use among people with dementia—a six-month follow-up study. BMC Pharmacol Toxicol 14:56. https://doi.org/10.1186/2050-6511-14-56
Sanger DJ (2004) The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs 18:9–15
Dolder C, Nelson M, McKinsey J (2007) Use of non-benzodiazepine hypnotics in the elderly: are all agents the same? CNS Drugs 21:389–405
Fastbom J, Johnell K (2015) National indicators for quality of drug therapy in older persons: the Swedish experience from the first 10 years. Drugs Aging 32:189–199. https://doi.org/10.1007/s40266-015-0242-4
Schwartz S (2013) Sleep disorders. In: Wehling M (ed) Drug therapy for the elderly. Springer, Wien, pp 215–227. https://doi.org/10.1007/978-3-7091-0912-0
Levy HB (2014) Non-benzodiazepine hypnotics and older adults: what are we learning about zolpidem? Expert Rev Clin Pharmacol 7:5–8. https://doi.org/10.1586/17512433.2014.864949
Bakken MS, Engeland A, Engesaeter LB et al (2014) Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol 70:873–880. https://doi.org/10.1007/s00228-014-1684-z
Parsaik AK, Mascarenhas SS, Khosh-Chashm D et al (2016) Mortality associated with anxiolytic and hypnotic drugs—a systematic review and meta-analysis. Aust N Z J Psychiatry 50:520–533. https://doi.org/10.1177/0004867415616695
Allain H, Bentue-Ferrer D, Tarral A et al (2003) Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo. Eur J Clin Pharmacol 59:179–188. https://doi.org/10.1007/s00228-003-0591-5
Mets MA, Volkerts ER, Olivier B et al (2010) Effect of hypnotic drugs on body balance and standing steadiness. Sleep Med Rev 14:259–267. https://doi.org/10.1016/j.smrv.2009.10.008
Shuto H, Imakyure O, Matsumoto J et al (2010) Medication use as a risk factor for inpatient falls in an acute care hospital: a case-crossover study. Br J Clin Pharmacol 69:535–542. https://doi.org/10.1111/j.1365-2125.2010.03613.x
Finkle WD, Der JS, Greenland S et al (2011) Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 59:1883–1890. https://doi.org/10.1111/j.1532-5415.2011.03591.x
Fleming J, Matthews FE, Brayne C (2008) Falls in advanced old age: recalled falls and prospective follow-up of over-90-year-olds in the Cambridge City over-75s cohort study. BMC Geriatr 8:6. https://doi.org/10.1186/1471-2318-8-6
Funding
SHADES was financially supported by the Medical Research Council of Southeast Sweden (FORSS) and Futurum—Academy of Health and Care, Region Jönköping County.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there are no conflicts of interest.
Statement of human and animal rights
The SHADES study protocol was approved by the Regional Ethical Review Board, Linköping (nos.: M150-07 and 2016/67-32).
Informed consent
Written informed consent was obtained from all study subjects. For subjects with cognitive impairment who were unable to understand the information, the next of kin were consulted.
Rights and permissions
About this article
Cite this article
Westerlind, B., Östgren, C.J., Mölstad, S. et al. Use of non-benzodiazepine hypnotics is associated with falls in nursing home residents: a longitudinal cohort study. Aging Clin Exp Res 31, 1087–1095 (2019). https://doi.org/10.1007/s40520-018-1056-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-018-1056-0